MedTrace Logo

Effects of Low/No Calorie Sweeteners on Glucose Tolerance

NCT04904133 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2021-05-27

No results posted yet for this study

Summary

This study aims to determine the effects of chronic exposure to some low/no calorie sweeteners (LNCS) on glucose tolerance and glucagon like peptide 1 (GLP-1) release in healthy individuals. LNCS examined in this study are saccharin, sucralose and aspartame+acesulfame-K. The amounts of LNCS given to the participants are kept similar to daily life exposure; far less than the Acceptable Daily Intakes (ADIs) levels proposed by Food and Drug Administration (FDA) or European Food Safety Authority (EFSA).

Conditions

  • Healthy Population
  • Glucose Tolerance

Interventions

OTHER

Low/No Calorie Sweeteners

LNCS powdered and then dissolved in water.

OTHER

Placebo Group

Water

Sponsors & Collaborators

  • Acibadem University

    lead OTHER

Principal Investigators

  • Saziye E Orku, Dr. · Acibadem University

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-02
Primary Completion
2019-05-12
Completion
2019-07-02

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04904133 on ClinicalTrials.gov